Katja Aviszus

Katja Aviszus

Auto-generated profile, based on publicly available information

Katja Aviszus

Department of Immunology and Genomic Medicine, National Jewish Health, Denver, Colorado, USA

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2016 in The Journal of Immunology
Verified
Journal Article
Closed access
PDF file
YHYafei Huang
Yafei Huang
AGAndrew Getahun
Andrew Getahun
RHRyan A Heiser
Ryan A Heiser
TDThiago O Detanico
Thiago O Detanico
KAKatja Aviszus
Katja Aviszus
WBWilli K. Born
Willi K. Born
We previously reported that selective ablation of certain γδ T cell subsets, rather than removal of all γδ T cells, strongly affects serum Ab levels in nonimmunized mice. This type of manipulation also changed T cells, including residual γδ T cells, revealing some interdependence of γδ T cell populations. For example, in mice lacking Vγ4+ and Vγ6+ γδ T cells (B6.TCR-Vγ4−/−/6−/−), we observed expanded Vγ1+ cells, which changed in composition and activation and produced more IL-4 upon stimulation in vitro, increased IL-4 production by αβ T cells as well as spontaneous germinal center formation in the spleen, and elevated serum Ig and autoantibodies. We therefore examined B cell populations in this and other γδ-deficient mouse strains. Whereas immature bone marrow B cells remained largely unchanged, peripheral B cells underwent several changes. Specifically, transitional and mature B cells in the spleen of B6.TCR-Vγ4−/−/6−/− mice and other peripheral B cell populations were diminished, most of all splenic marginal zone (MZ) B cells. However, relative frequencies and absolute numbers of Ab-producing cells, as well as serum levels of Abs, IL-4, and BAFF, were increased. Cell transfers confirmed that these changes are directly dependent on the altered γδ T cells in this strain and on their enhanced potential of producing IL-4. Further evidence suggests the possibility of direct interactions between γδ T cells and B cells in the splenic MZ. Taken together, these data demonstrate the capability of γδ T cells of modulating size and productivity of preimmune peripheral B cell populations.

18 April 2022 in The FASEB Journal
Verified
Journal Article
Open access
MKManale El Kharbili
Manale El Kharbili
KAKatja Aviszus
Katja Aviszus
SSSarah K. Sasse
Sarah K. Sasse
Xiaoyun ZhaoXiaoyun Zhao
Xiaoyun Zhao
KSKarina A. Serban
Karina A. Serban
FGFabienne Gally
Fabienne Gally
Resolution of inflammation is an active process that is tightly regulated to achieve repair and tissue homeostasis. In the absence of resolution, persistent inflammation underlies the pathogenesis of chronic lung disease such as chronic obstructive pulmonary disease (COPD) with recurrent exacerbations. Over the course of inflammation, macrophage programming transitions from pro‐inflammatory to pro‐resolving, which is in part regulated by the nuclear receptor Peroxisome Proliferator‐Activated Receptor γ (PPARγ). Our previous work demonstrated an association between Fatty Acid Binding Protein 5 (FABP5) expression and PPARγ activity in peripheral blood mononuclear cells of healthy and COPD patients. However, a role for FABP5 in macrophage programming has not been examined. Here, using a combination of in vitro and in vivo approaches, we demonstrate that FABP5 is necessary for PPARγ activation. In turn, PPARγ acts directly to increase FABP5 expression in primary human alveolar macrophages. We further illustrate that lack of FABP5 expression promotes a pro‐inflammatory macrophage programming with increased secretion of pro‐inflammatory cytokines and increased chromatin accessibility for pro‐inflammatory transcription factors (e.g., NF‐κB and MAPK). And finally, real‐time cell metabolic analysis using the Seahorse technology shows an inhibition of oxidative phosphorylation in FABP5‐deficient macrophages. Taken together, our data indicate that FABP5 and PPARγ reciprocally regulate each other's expression and function, consistent with a novel positive feedback loop between the two factors that mediates macrophage pro‐resolving programming. Our studies highlight the importance of defining targets and regulatory mechanisms that control the resolution of inflammation and may serve to inform novel interventional strategies directed towards COPD.

Verified
Journal Article
Open access
PDF file
HLHaolin Liu
Haolin Liu
PWPengcheng Wei
Pengcheng Wei
KAKatja Aviszus
Katja Aviszus
QZQianqian Zhang
Qianqian Zhang
JLJared Linderberger
Jared Linderberger
GZGongyi Zhang
Gongyi Zhang
The SARS-CoV-2 Delta and Lambda variants had been named variants of concern (VOC) and variants of interest (VOI), respectively, by the World Health Organization (WHO). Both variants have two mutations in the spike receptor binding domain (RBD) region, with L452R and T478K mutations in the Delta variant, and L452Q and F490S mutations in the Lambda variant. We used surface plasmon resonance (SPR)-based technology to evaluate the effect of these mutations on human angiotensin-converting enzyme 2 (ACE2) and Bamlanivimab binding. The affinity for the RBD ligand, ACE2, of the Delta RBD is approximately twice as strong as that of the wild type RBD, an increase that accounts for the increased infectivity of the Delta variant. On the other hand, in spite of its amino acid changes, the Lambda RBD has similar affinity to ACE2 as the wild type RBD. The protective anti-wild type RBD antibody Bamlanivimab binds very poorly to the Delta RBD and not at all to the Lambda RBD. Nevertheless, serum antibodies from individuals immunized with the BNT162b2 vaccine were found to bind well to the Delta RBD, but less efficiently to the Lambda RBD in contrast. As a result, the blocking ability of ACE2 binding by serum antibodies was decreased more by the Lambda than the Delta RBD. Titers of sera from BNT162b2 mRNA vaccinated individuals dropped 3-fold within six months of vaccination regardless of whether the target RBD was wild type, Delta or Lambda. This may account partially for the fall off with time in the protective effect of vaccines against any variant.

19 December 2023 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
MKManale El Kharbili
Manale El Kharbili
SSSarah K. Sasse
Sarah K. Sasse
LSLynn Sanford
Lynn Sanford
SJSean Jacobson
Sean Jacobson
KAKatja Aviszus
Katja Aviszus
FGFabienne Gally
Fabienne Gally

1 May 2023
Verified
Conference Paper
Closed access
FGF.S. Gally
F.S. Gally
MKM. El Kharbili
M. El Kharbili
Xiaoyun ZhaoXiaoyun Zhao
Xiaoyun Zhao
KAK. Aviszus
K. Aviszus

23 June 2026 in Journal of Lipid Research
Verified
Journal Article
Open access
JRJack H. Ratliff
Jack H. Ratliff
KAKatja Aviszus
Katja Aviszus
SASophia Addi
Sophia Addi
MKManale El Kharbili
Manale El Kharbili
SFSteven Fujaros
Steven Fujaros
FGFabienne Gally
Fabienne Gally
Macrophages are large mononuclear immune cells that participate in host protection, not only by phagocytosing foreign or infected cells and initiating inflammatory responses, but also by contributing to the resolution of inflammation. Chronic Obstructive Pulmonary Disease (COPD) is characterized by increased numbers of macrophages in lung tissue, with altered engulfment capabilities. However, the molecular pathways leading to macrophage dysfunction in COPD remain unclear. Using integrated genetics and genomics approaches, we previously identified Fatty Acid Binding Protein 5 (FABP5) as a key target in the resolution of airway inflammation that exhibits decreased expression in COPD patients. The objective is to define the significance of alveolar macrophage FABP5 by comparing the resolution of inflammation in WT and Fabp5-/- mice following nontypeable Haemophilus influenzae (NTHi) infection or LPS sterile inflammation. Immune and metabolic responses were analyzed using functional assays, flow cytometry, ELISA, cell metabolic profiling and tracing, as well as ATAC-seq. Fabp5-/- mice exhibited impaired efferocytosis, reflected by a reduction of apoptotic cell engulfment by alveolar macrophages. This was accompanied by a reduction in fatty acid uptake and fatty acid β-oxidation, a reduction in mitochondrial respiration, an accumulation of TCA cycle and glycolysis metabolites, and an increased chromatin accessibility for AP-1 family members. Fabp5-deficient alveolar macrophages failed to initiate reparative metabolic programming, which is critical for the resolution of inflammation. Our data suggest that increasing FABP5 expression could provide a metabolic switch that facilitates macrophage conversion to a pro-resolving phenotype and restores alveolar macrophage efferocytic functions in the lungs of COPD patients.